-
Tarsus Pharmaceuticals (NASDAQ:TARS) Earns Buy Rating from Guggenheim
Source: Buzz FX / 24 Feb 2025 09:36:17 America/Chicago
Tarsus Pharmaceuticals (NASDAQ:TARS) Earns Buy Rating from Guggenheim Written by MarketBeat February 24, 2025 Share Link copied to clipboard. Tarsus Pharmaceuticals ( NASDAQ:TARS - Get Free Report ) 's stock had its "buy" rating reissued by
Read more...